Literature DB >> 8795494

Streptokinase versus alteplase in acute myocardial infarction.

H S Friedman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8795494      PMCID： PMC1295882          DOI： 10.1177/014107689608900804

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  17 in total

1.  The demise of the randomized controlled trial.

Authors:  J Herman
Journal:  J Clin Epidemiol       Date:  1995-07       Impact factor: 6.437

2.  Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1.

Authors:  P M Ridker; C O'Donnell; V J Marder; C H Hennekens
Journal:  Ann Intern Med       Date:  1993-09-15       Impact factor: 25.391

3.  Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction.

Authors:  S D Bleich; T C Nichols; R R Schumacher; D H Cooke; D A Tate; S L Teichman
Journal:  Am J Cardiol       Date:  1990-12-15       Impact factor: 2.778

4.  A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.

Authors:  J Hsia; W P Hamilton; N Kleiman; R Roberts; B R Chaitman; A M Ross
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

5.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

6.  Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.

Authors:  D P de Bono; M L Simoons; J Tijssen; A E Arnold; A Betriu; C Burgersdijk; L López Bescos; E Mueller; M Pfisterer; F Van de Werf
Journal:  Br Heart J       Date:  1992-02

7.  The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.

Authors:  K A Reimer; R B Jennings
Journal:  Lab Invest       Date:  1979-06       Impact factor: 5.662

8.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; M Takayama; A Maslowski; N M Bass; J A Ormiston; T Whitlock
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

9.  A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.

Authors:  E J Topol; B S George; D J Kereiakes; D C Stump; R J Candela; C W Abbottsmith; L Aronson; A Pickel; J M Boswick; K L Lee
Journal:  Circulation       Date:  1989-02       Impact factor: 29.690

10.  Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.

Authors:  M L Simoons; A E Arnold; A Betriu; D P de Bono; J Col; F C Dougherty; R von Essen; H Lambertz; J Lubsen; B Meier
Journal:  Lancet       Date:  1988-01-30       Impact factor: 79.321
View more
  1 in total

Review 1.  Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.

Authors:  B J Smith
Journal:  J Accid Emerg Med       Date:  1999-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.